Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2022 Jan 11;29(2):682. doi: 10.1111/ene.15187

Corrigendum

PMCID: PMC9050108  PMID: 35018702

In the article by Jakubíková et al. [1], the grant number from the Ministry of Health of the Czech Republic was missed out under the Funding Information section on page 3418. The complete funding information should read:

Funding information

General University Hospital GIP‐20‐L‐14‐212, Ministry of Health of the Czech Republic MH CZ‐DRO‐VFN64165, General University Hospital in Prague Ref. RVO (FNBr, 65269705), Project of specific research Ref. MUNI/A/1600/2020 Brno and the European Reference Network for Neuromuscular Diseases – Project ID 870177. Patient recruitment was partially performed using the National Myasthenia Gravis Registry.

The authors apologise for the error.

REFERENCE

  • 1. Jakubíková M, Týblová M, Tesař A, et al. Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival. Eur J Neurol. 2021;28:3418‐3425. 10.1111/ene.14951 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from European Journal of Neurology are provided here courtesy of Wiley

RESOURCES